Akihito Ishigami

6.5k total citations
194 papers, 5.2k citations indexed

About

Akihito Ishigami is a scholar working on Molecular Biology, Nutrition and Dietetics and Physiology. According to data from OpenAlex, Akihito Ishigami has authored 194 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 57 papers in Nutrition and Dietetics and 47 papers in Physiology. Recurrent topics in Akihito Ishigami's work include Vitamin C and Antioxidants Research (54 papers), Rheumatoid Arthritis Research and Therapies (20 papers) and Vitamin D Research Studies (18 papers). Akihito Ishigami is often cited by papers focused on Vitamin C and Antioxidants Research (54 papers), Rheumatoid Arthritis Research and Therapies (20 papers) and Vitamin D Research Studies (18 papers). Akihito Ishigami collaborates with scholars based in Japan, South Korea and United States. Akihito Ishigami's co-authors include Naoki Maruyama, Hiroaki Asaga, Yoshitaka Kondo, Setsuko Handa, Sataro Goto, Tatsuo Senshu, Kentaro Shimokado, Takako Ohsawa, Yasunori Sato and Akiko Amano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Akihito Ishigami

189 papers receiving 5.2k citations

Peers

Akihito Ishigami
Anna Nicolaou United Kingdom
Young Yang South Korea
Gabriel Fernandes United States
Wei Hu China
Anna Nicolaou United Kingdom
Akihito Ishigami
Citations per year, relative to Akihito Ishigami Akihito Ishigami (= 1×) peers Anna Nicolaou

Countries citing papers authored by Akihito Ishigami

Since Specialization
Citations

This map shows the geographic impact of Akihito Ishigami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihito Ishigami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihito Ishigami more than expected).

Fields of papers citing papers by Akihito Ishigami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihito Ishigami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihito Ishigami. The network helps show where Akihito Ishigami may publish in the future.

Co-authorship network of co-authors of Akihito Ishigami

This figure shows the co-authorship network connecting the top 25 collaborators of Akihito Ishigami. A scholar is included among the top collaborators of Akihito Ishigami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihito Ishigami. Akihito Ishigami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Hongsik, et al.. (2025). GAPDH citrullination as a molecular signature of neurodegeneration, assessed in prion diseases. Journal of Alzheimer s Disease. 108(4). 1520–1536.
2.
Sato, Yasunori, et al.. (2025). Vitamin C Promotes Epidermal Proliferation by Promoting DNA Demethylation of Proliferation-Related Genes in Human Epidermal Equivalents. Journal of Investigative Dermatology. 145(11). 2775–2788.e14. 2 indexed citations
3.
Yoshida, Yohko, Shujiro Okuda, Manabu Abe, et al.. (2024). PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis. The EMBO Journal. 43(21). 4846–4869. 5 indexed citations
4.
Manikandan, R., Jae‐Hoon Kim, Akihito Ishigami, et al.. (2023). Dispersant-free supra single-walled carbon nanotubes for simultaneous and highly sensitive biomolecule sensing in ex vivo mouse tissues. Carbon. 213. 118275–118275. 20 indexed citations
5.
Inoue, Hirofumi, Akihito Ishigami, Ayami Sato, et al.. (2023). Release of SMP30 in Extracellular Vesicles under Conditions of Ascorbic Acid Deficiency Is Involved with Acute Phase Response in ODS Rat. Journal of Nutritional Science and Vitaminology. 69(6). 420–427.
6.
Inoue, Hirofumi, Miori Tanaka, Ayami Sato, et al.. (2023). Resveratrol Upregulates Senescence Marker Protein 30 by Activating AMPK/Sirt1-Foxo1 Signals and Attenuating H<sub>2</sub>O<sub>2</sub>-Induced Damage in FAO Rat Liver Cells. Journal of Nutritional Science and Vitaminology. 69(5). 388–393. 4 indexed citations
7.
Uchida, Takahiro, Yoshitaka Kondo, Hiroaki Kobayashi, et al.. (2020). Radiation-induced gastrointestinal syndrome is exacerbated in vitamin C–insufficient SMP30/GNL knockout mice. Nutrition. 81. 110931–110931. 4 indexed citations
8.
Tsubota, Maho, et al.. (2019). Dietary ascorbic acid restriction in GNL/SMP30-knockout mice unveils the role of ascorbic acid in regulation of somatic and visceral pain sensitivity. Biochemical and Biophysical Research Communications. 511(3). 705–710. 3 indexed citations
9.
Kim, Sung Eun, Ji Won Park, Byungki Jang, et al.. (2018). Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis. PLoS ONE. 13(8). e0201744–e0201744. 14 indexed citations
10.
Matsumoto, Isao, Atsumu Osada, Izumi Kurata, et al.. (2018). Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis. Arthritis Research & Therapy. 20(1). 66–66. 17 indexed citations
11.
Arito, Mitsumi, Hidetaka Onodera, Kazuki Omoteyama, et al.. (2016). Hypoxia-induced production of peptidylarginine deiminases and citrullinated proteins in malignant glioma cells. Biochemical and Biophysical Research Communications. 482(1). 50–56. 23 indexed citations
12.
Lee, Yujeong, et al.. (2016). Neuroprotective and anti‐inflammatory effects of morin in a murine model of Parkinson's disease. Journal of Neuroscience Research. 94(10). 865–878. 67 indexed citations
13.
Yamauchi, H., Shunsuke Miura, Takashi Owada, et al.. (2016). Senescence marker protein-30 deficiency impairs angiogenesis under ischemia. Free Radical Biology and Medicine. 94. 66–73. 12 indexed citations
14.
Wizeman, John, Anthony P. Nicholas, Akihito Ishigami, & Royce Mohan. (2016). Citrullination of glial intermediate filaments is an early response in retinal injury.. PubMed Central. 22. 1137–1155. 19 indexed citations
15.
Umeda, N., Isao Matsumoto, Yuya Kondo, et al.. (2015). Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases. Clinical Rheumatology. 35(5). 1181–1188. 19 indexed citations
16.
Shimada, Nobuko, Setsuko Handa, Yoshiaki Uchida, et al.. (2009). Developmental and age‐related changes of peptidylarginine deiminase 2 in the mouse brain. Journal of Neuroscience Research. 88(4). 798–806. 29 indexed citations
17.
Jang, Byungki, Eunah Kim, Jin-Kyu Choi, et al.. (2008). Accumulation of Citrullinated Proteins by Up-Regulated Peptidylarginine Deiminase 2 in Brains of Scrapie-Infected Mice. American Journal Of Pathology. 173(4). 1129–1142. 54 indexed citations
18.
Sato, Tadashi, Kuniaki Seyama, Yasunori Sato, et al.. (2006). Senescence Marker Protein-30 Protects Mice Lungs from Oxidative Stress, Aging, and Smoking. American Journal of Respiratory and Critical Care Medicine. 174(5). 530–537. 122 indexed citations
19.
Ishigami, Akihito, et al.. (2005). . Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 42(5). 519–522. 1 indexed citations
20.
Ishigami, Akihito, Toshiko Fujita, Setsuko Handa, et al.. (2002). Senescence Marker Protein-30 Knockout Mouse Liver Is Highly Susceptible to Tumor Necrosis Factor-α- and Fas-Mediated Apoptosis. American Journal Of Pathology. 161(4). 1273–1281. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026